Literature DB >> 17888048

Development of parapneumonic empyema in children.

Elina Lahti1, Ville Peltola, Raimo Virkki, Markku Alanen, Olli Ruuskanen.   

Abstract

AIM: The aim of the study was to find clinical predictors for parapneumonic empyema in children.
METHODS: Thirty-seven children treated for parapneumonic empyema at the Department of Pediatrics, Turku University Hospital, were retrospectively evaluated. Two distinct comparison groups of children with uncomplicated community-acquired pneumonia with alveolar consolidation (n = 37 in both groups) were included. Clinical and laboratory data on admission as well as fever kinetics and inflammatory markers during hospitalization were analyzed.
RESULTS: In a multivariate analysis, a history of prolonged fever, tachypnoea and pain on abdominal palpation on admission were the most significant clinical predictors for empyema. On admission, serum C-reactive protein levels were higher among children with empyema than among those with uncomplicated pneumonia (means, 234 mg/L vs. 178 mg/L; p = 0.037). During hospitalization, prolonged fever and persistence of high serum C-reactive protein levels were associated with empyema. At the initial evaluation, pleural fluid was not reported in 35% of children with empyema.
CONCLUSIONS: Early recognition of developing empyema is challenging. Children with pneumonia presenting with prolonged fever, tachypnoea, pain on abdominal palpation and high serum C-reactive protein levels are at risk for parapneumonic empyema.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888048     DOI: 10.1111/j.1651-2227.2007.00511.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Timely thoracoscopic decortication promotes the recovery of paediatric parapneumonic empyema.

Authors:  C T Lau; C H Fung; K K Y Wong; P Tam
Journal:  Pediatr Surg Int       Date:  2015-06-03       Impact factor: 1.827

3.  Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.

Authors:  Todd A Florin; Lilliam Ambroggio; Cole Brokamp; Yin Zhang; Mantosh Rattan; Eric Crotty; Michael A Belsky; Sara Krueger; Thomas N Epperson; Andrea Kachelmeyer; Richard Ruddy; Samir S Shah
Journal:  Pediatrics       Date:  2020-05-13       Impact factor: 7.124

4.  A persistently elevated C-reactive protein level in pneumonia may indicate empyema.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2008       Impact factor: 9.097

5.  Prediction of delayed recovery from pediatric community-acquired pneumonia.

Authors:  Massimiliano Don; Francesca Valent; Mario Canciani; Matti Korppi
Journal:  Ital J Pediatr       Date:  2010-07-29       Impact factor: 2.638

6.  Magnetic resonance imaging of lung infections in children.

Authors:  Ville Peltola; Olli Ruuskanen; Erkki Svedström
Journal:  Pediatr Radiol       Date:  2008-08-23

Review 7.  Common pediatric respiratory emergencies.

Authors:  Joseph Choi; Gary L Lee
Journal:  Emerg Med Clin North Am       Date:  2011-12-17       Impact factor: 2.264

8.  Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital.

Authors:  Anne Rowan-Legg; Nicholas Barrowman; Nazih Shenouda; Khaldoun Koujok; Nicole Le Saux
Journal:  BMC Pediatr       Date:  2012-08-28       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.